We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+8.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.2B
AUM Growth
+$642M
Cap. Flow
-$66.7M
Cap. Flow %
-0.59%
Top 10 Hldgs %
52.34%
Holding
1,116
New
76
Increased
314
Reduced
582
Closed
97

Sector Composition

Rank Sector Weight
1 Energy 63.96%
2 Technology 5.43%
3 Healthcare 4.22%
4 Consumer Discretionary 3.76%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FULC icon
951
Fulcrum Therapeutics
FULC
$248M
$257K ﹤0.01%
+35,358
New +$231K
CMA
952
DELISTED
Comerica
CMA
$257K ﹤0.01%
3,843
-16
-0.4% -$1.11K
AURA icon
953
Aura Biosciences
AURA
$729M
$257K ﹤0.01%
+24,432
New +$311K
FRC
954
DELISTED
First Republic Bank
FRC
$256K ﹤0.01%
2,098
PDSB icon
955
PDS Biotechnology
PDSB
$38.1M
$256K ﹤0.01%
+19,367
New +$137K
WMK icon
956
Weis Markets
WMK
$1.82B
$255K ﹤0.01%
+3,099
New +$262K
HBNC icon
957
Horizon Bancorp
HBNC
$1.03B
$255K ﹤0.01%
16,899
-109
-0.6% -$1.8K
KOD icon
958
Kodiak Sciences
KOD
$2.59B
$255K ﹤0.01%
35,546
+7,184
+25% +$51.6K
LCII icon
959
LCI Industries
LCII
$2.51B
$253K ﹤0.01%
2,741
WST icon
960
West Pharmaceutical
WST
$23.1B
$253K ﹤0.01%
1,075
-10
-0.9% -$2.37K
WSM icon
961
Williams-Sonoma
WSM
$26.7B
$252K ﹤0.01%
4,388
-24
-0.5% -$1.44K
RRC icon
962
Range Resources
RRC
$9.11B
$252K ﹤0.01%
10,074
ASLE icon
963
AerSale
ASLE
$292M
$250K ﹤0.01%
15,435
-71
-0.5% -$1.23K
WAL icon
964
Western Alliance Bancorporation
WAL
$9.07B
$250K ﹤0.01%
4,197
-26
-0.6% -$1.68K
ALE
965
DELISTED
Allete
ALE
$249K ﹤0.01%
+3,861
New +$229K
ABUS icon
966
Arbutus Biopharma
ABUS
$865M
$248K ﹤0.01%
106,230
+24,352
+30% +$58.3K
SBOW
967
DELISTED
SilverBow Resources, Inc.
SBOW
$247K ﹤0.01%
8,748
STOK icon
968
Stoke Therapeutics
STOK
$1.82B
$247K ﹤0.01%
26,749
+5,234
+24% +$54.4K
ICE icon
969
Intercontinental Exchange
ICE
$82.4B
$247K ﹤0.01%
2,403
SM icon
970
SM Energy
SM
$7.96B
$246K ﹤0.01%
7,075
AR icon
971
Antero Resources
AR
$10.9B
$246K ﹤0.01%
7,946
ELS icon
972
Equity Lifestyle Properties
ELS
$12.8B
$246K ﹤0.01%
3,806
-1,225
-24% -$77.6K
CSL icon
973
Carlisle Companies
CSL
$13.6B
$246K ﹤0.01%
1,043
-6
-0.6% -$1.54K
ALLY icon
974
Ally Financial
ALLY
$13.1B
$242K ﹤0.01%
9,906
UAN icon
975
CVR Partners
UAN
$1.3B
$241K ﹤0.01%
2,392
-5
-0.2% -$588

Similar funds

ALPS Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, ALPS Advisors held 1,116 positions worth $11.2B, up 6.1% from $10.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

ALPS Advisors's Q4 2022 filing shows 76 new, 314 increased, 582 reduced and 97 closed positions. Its largest new stake was Albemarle: 124,308 shares worth $27M. The largest sale was Shell Midstream Partners, L.P., an estimated $280M.

By sector, the portfolio is most concentrated in Energy at 64% of assets, up from 63% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2022 buy was Albemarle: 124,308 shares worth $27M.
  • ALPS Advisors added most to Crestwood Equity Partners LP in Q4 2022, an estimated $62.5M increase.
  • ALPS Advisors's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $28.2M.
  • ALPS Advisors fully exited Shell Midstream Partners, L.P. in Q4 2022, selling an estimated $280M.
  • ALPS Advisors's ten largest holdings make up 52% of its $11.2B portfolio in Q4 2022.
  • ALPS Advisors opened 76 new positions and closed 97 in Q4 2022.
  • ALPS Advisors's portfolio value rose 6.1% quarter-over-quarter to $11.2B.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.